New strategies in melanoma therapy: can nanoparticles overcome chemoresistance?-Reference-Cited by-同舟云学术

New strategies in melanoma therapy: can nanoparticles overcome chemoresistance?

Published:2017-07 Issue:14 Volume:12 Page:1623-1626
ISSN:1743-5889
Container-title:Nanomedicine
language:en
Short-container-title:Nanomedicine

Author:

Badea Ildiko¹

Affiliation:

1. College of Pharmacy & Nutrition, University of Saskatchewan, 107 Wiggins Road, Health Sciences Building, Room 3D01.5, Box 3D01–13, Saskatoon, Saskatchewan, S7N 5E5, Canada

Publisher

Future Medicine Ltd

Subject

Development,General Materials Science,Biomedical Engineering,Medicine (miscellaneous),Bioengineering

Link

https://www.futuremedicine.com/doi/pdf/10.2217/nnm-2017-0145

Reference18 articles.

1. National Cancer Institute. www.cancer.gov.

2. Recent advances in targeted nanoparticles drug delivery to melanoma

3. Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications

4. Nanoparticle targeting of anti-cancer drugs that alter intracellular signaling or influence the tumor microenvironment

5. Nanoparticle-mediated drug delivery for treating melanoma

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implications of nanotherapeutic advancements to leverage multi-drug resistant breast cancer: The state-of-the-art review;Journal of Drug Delivery Science and Technology;2024-10

2. Quercetin and its nanoformulations as promising agents for lung cancer treatment: A focus on molecular mechanisms;Journal of Drug Delivery Science and Technology;2024-09

3. Nanotechnology-empowered strategies in treatment of skin cancer;Environmental Research;2023-10

4. Long non-coding RNA CCHE1 modulates LDHA-mediated glycolysis and confers chemoresistance to melanoma cells;Cancer & Metabolism;2023-07-21

5. Polymersomes as versatile drug delivery vesicular carriers;Systems of Nanovesicular Drug Delivery;2022